Trial NCT00968331

View at ClinicalTrials.gov 
Org. Study IDs: REVLIRIT01

Last trial update was posted on 2012-08-27

MeSH Interventions

Lenalidomide Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse Large B-cell Lymphoma

Stopping Reasons

The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID